Outcomes and changes in code status of patients with acute myeloid leukemia undergoing induction chemotherapy who were transferred to the intensive care unit-Reference-Cited by-同舟云学术

Outcomes and changes in code status of patients with acute myeloid leukemia undergoing induction chemotherapy who were transferred to the intensive care unit

Published:2017-11 Issue: Volume:62 Page:51-55
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Ahmed Tamjeed,Koch Abby L.,Isom Scott,Klepin Heidi D.,Bishop Jonathan M.,Ellis Leslie R.,Berenzon Dmitriy,Howard Dianna,Lyerly Susan,Powell Bayard L.,Pardee Timothy S.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference12 articles.

1. Acute myeloid leukemia: epidemiology and etiology;Deschler;Cancer,2006

2. Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia;Yates;Cancer Chemother. Rep.,1973

3. Intensive care unit management of patients with newly diagnosed acute myeloid leukemia with no organ failure;Lengline;Leuk. Lymphoma,2012

4. Outcomes and prognostic factors for patients with acute myeloid leukemia admitted to the intensive care unit;Jackson;Leuk. Lymphoma,2014

5. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel;Dohner;Blood,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapy with hypomethlyating agents/venetoclax in patients with newly diagnosed acute myeloid leukaemia requiring admission to the intensive care unit: Possible reduction in side effects with preserved efficacy;British Journal of Haematology;2024-01-16

2. Venetoclax and hypomethylating agents in critically ill patients with newly diagnosed acute myeloid leukaemia;British Journal of Haematology;2024-01-05

3. Outcome of patients with newly diagnosed AML admitted to the ICU, including preemptive admission – a multi-center study;Annals of Hematology;2023-04-11

4. Code status transitions in patients with high-risk acute myeloid leukemia;Blood Advances;2022-07-20

5. Reduce Mortality and Morbidity in Acute Myeloid Leukemia With Hyperleukocytosis With Early Admission in Intensive Care Unit: A Retrospective Analysis;Journal of Hematology;2020